Fundamentals of Pharmaceutical and Biologics Regulations (subscription)

Subscribe and get the latest pharmaceuticals and biologics fundamentals as they release with this three-year subscription.

Table of Contents

Section I: General Information

  • Chapter 1: Healthcare Landscape and Drug Development
  • Chapter 2: The Drug Development Continuum, Preclinical to Market Access
  • Chapter 3: International Harmonization via ICH, WHO, and other Global Initiatives

Section II: Nonclinical Studies

  • Chapter 4: Principles of Good Laboratory Practice and Nonclinical Development
  • Chapter 5: Safety Pharmacology Studies
  • Chapter 6: Pharmacokinetic and Toxicokinetic Studies
  • Chapter 7: Genotoxicity Studies
  • Chapter 8: Carcinogenicity Studies
  • Chapter 9: Developmental and Reproductive Toxicity Assessments
  • Chapter 10: Regulatory Environmental Risk Assessment of Human Pharmaceuticals

Section III: Chemistry, Manufacturing, Controls

  • Chapter 11: The Global Regulatory Process for the Registration of Active Substances
  • Chapter 12: Coordinating Drug Supply for Clinical and Non-Clinical Development
  • Chapter 13: Pharmaceutical Development Studies and Manufacturing Experience
  • Chapter 14: Analytical Development – Testing & Stability

Section IV: Clinical Trials

  • Chapter 15: Application Submission Types and Required Data (and History)
  • Chapter 16: Phases of Development (1,2,3,4)
  • Chapter 17: Enhancing Diversity in Clinical Trials
  • Chapter 18: Health Authority Interactions
  • Chapter 19: Pediatrics
  • Chapter 20: Regional-Specific Studies

Section V: Marketing Authorization

  • Chapter 21: Framework for Benefit-Risk Assessment
  • Chapter 22: eCTD and Digital Applications
  • Chapter 23: Expedited Approval Pathways
  • Chapter 24: Dossier Requirements

Section VI: Postmarketing Authorization

  • Chapter 25: Postauthorization Commitments
  • Chapter 26: Transfers and Renewals
  • Chapter 27: Product Extensions, Variations, and Supplements
  • Chapter 28: Compliance
  • Chapter 29: Recalls
  • Chapter 30: Postmarket Surveillance
  • Chapter 31: Advertising and Promotion
  • Chapter 32: Market Access—Reimbursement and Pricing

Linda McBride, RPh, RAC-US and Siegfried Schmitt, PhD, editors

Contributing Authors


About the Book

Available formats: print, e-book, and 3-year digital subscription

In a global regulatory environment, finding the information necessary to move a medicinal product to market can be daunting. There is no one-stop reference that covers the entire drug lifecycle – until now.

Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, is the reference you are searching for. Consolidating the knowledge of more than 50 subject matter experts across 32 chapters, this book places all the laws, regulations, and guidances needed at your fingertips – whether accessed via the hardcover book or searched for in the e-book.

In a world of global commerce, most regulatory professionals must interact with regulators in multiple jurisdictions. The relevant information is widely dispersed. With Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, you can find much of what you need, including additional background information, such as actual approval timelines versus timelines suggested by the regulators, in just one place.

This brand-new book includes sections covering general information; nonclinical safety; chemistry, manufacturing, and controls (CMC); clinical trials; and marketing authorization, as well as explanations of guidances from the usual suspects – the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), the International Council on Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). Added to that, the authors have combed the globe to include critical information from a host of additional regulators such as ANVISA, Health Canada, NMPA, ANMAT, COFEPRIS, TGA, MedSafe, PMDA, and more.


Who will benefit from this book?

Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective was developed for regulatory professionals of all levels of RAPS Regulatory Competency Framework including newcomers and seasoned professionals as well as academics and governmental employees. Regulatory professionals at Levels 1 and 2 of the framework will be able to easily access relevant drugs and biologics regulations and guidance in specific countries and how to apply them in one convenient place. For more senior professionals at Levels 3 and 4 responsible for global regulatory strategy, the book will serve as a valuable resource to facilitate strategic discussions on drugs and biologics regulations and policy worldwide.

Regulatory information is all over the place – there is an article here, a book chapter there. Some are in Chinese, some are in English, and others in yet another language. There was no comprehensive source for a global regulatory perspective on drugs and biologics. This is why this book is an absolute necessity.

Siegfried Schmitt, PhD

RAPS Editorial Advisory Committee


Purchasing Options

This book can be purchased in the following formats:

This book can also be purchased as part of the following bundles:

*All subscriptions listed above (excluding the All Access Library) are for three years. They grant you access to the products in the bundle. During this period, you can read the content online or download books as PDFs for offline use. You’ll also receive automatic updates to any new editions of the books and/or chapters included in your subscription. Learn more about subscriptions.


Published by RAPS © 2023. Hardcover. 656 pages. ISBN (print): 978-1-947493-86-5. ISBN (digital): 978-1-947493-87-2.

×

Welcome to the new RAPS Digital Experience

We have completed our migration to a new platform and are pleased to introduce the updated site.

What to expect: If you have an existing login, please RESET YOUR PASSWORD before signing in. After you log in for the first time, you will be prompted to confirm your profile preferences, which will be used to personalize content.

We encourage you to explore the new website and visit your updated My RAPS page. If you need assistance, please review our FAQ page.

We welcome your feedback. Please let us know how we can continue to improve your experience.